secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2025-11-20T23:59:59+00:00
Accession:  0001193125-25-290003
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 2.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro completes acquisition of IRRAS for $5M cash + 1.325M shares
----------------------------------------------------------------------------

- Acquisition closed Nov 20, 2025; IRRAS shareholders received $5M cash and 1.325M CLPT shares.
- Earnout consideration: 25% of net sales of certain IRRAS products above thresholds over three one-year periods.
- IRRAS brings IRRA flow fluid-exchange system for intracranial bleeding, 50+ active customers, and commercial team.
- ClearPoint Neuro expects expanded presence in neurocritical care and enhanced commercial scale from the deal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000119312525290003/0001193125-25-290003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000119312525290003/clpt-20251120.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-290003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer